Lanean...
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Precision medicine focuses on DNA abnormalities, but not all tumors have tractable genomic alterations. The WINTHER trial (NCT01856296) navigated patients to therapy on the basis of fresh biopsy-derived DNA sequencing (arm A; 236 gene panel) or RNA expression (arm B; comparing tumor to normal). The...
Gorde:
| Argitaratua izan da: | Nat Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599610/ https://ncbi.nlm.nih.gov/pubmed/31011205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-019-0424-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|